azomycin has been researched along with Peripheral Nervous System Diseases in 31 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 28 (90.32) | 18.7374 |
1990's | 2 (6.45) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (3.23) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Eells, SJ; Hernandez, S; Meymandi, SK; Miller, DA; Miller, LG; Rodriguez De Armas, L; Traina, MM | 1 |
Bataille, B; Becq-Giraudon, B; Desbordes, JM; Desplat, A; Maissin, F; Roualdes, G | 1 |
Hansen, HS; Hansen, JM; Kamieniecka, Z; Køhler, O; Melgaard, B; Paulson, OB; Pedersen, AG; Tang, X; Trojaborg, W | 1 |
Akhoush, H; Awwad, HK; Barsoum, M; El Badawy, S; el Baki, HA; El-Merzabani, M | 1 |
Ballon, SC; Coleman, CN; Halsey, J; Hirst, VK; Howes, AE; Martinez, A | 1 |
Gangji, D; Koziol, D; Partington, J; Phillips, TL; Schwade, JG; Strong, JM; Urtasun, R; Van Raalte, G; Wasserman, TH | 1 |
Strike, TA; Walker, MD | 1 |
Kogelnik, HD | 1 |
Dische, S; Saunders, MI; Stratford, MR | 1 |
Johnson, RJ; Levin, VA; Phillips, TL; VanRaalte, G; Wasserman, TH | 1 |
Dewar, AJ; Moffett, BJ; Rose, GP; Stratford, IJ | 1 |
Marten, TR | 1 |
Black, BE; Bush, RS; Cummings, BJ; Rauth, AM; Sorenti, VL; Thomas, GM | 1 |
Glatstein, E; Makuch, RW; Schwade, JG; Strong, JM | 1 |
Awwad, HK; Barsoum, M; El Badawy, S; El Baki, HA; El Merzabani, M; Ezzat, S; Omar, S; Zaki, A | 1 |
Hansen, HH; Kjaer, M; Panduro, J; Wolff-Jensen, J | 1 |
Anderson, P; Dische, S; Flockhart, IR; Saunders, ME | 1 |
Band, RP; Chapman, JD; Feldstein, ML; Marynowski, B; Rabin, HR; Shnitka, T; Starreveld, E; Urtasun, RC; Wilson, AF | 1 |
Jentzsch, K; Kärcher, KH; Kogelnik, HD; Maida, E; Mamoli, B; Meyer, JH; Szepesi, T; Wessely, P; Zaunbauer, F | 1 |
Dische, S; Flockhart, IR; Saunders, MI | 1 |
Anderson, P; Bleehen, N; Disch, S; Karcher, KH; Kogelnik, HD; Phillips, TL; Saunders, MI; Urtasun, RC; Wasserman, TH | 1 |
Gomer, CJ; Johnson, RJ; Lawrence, GA; Levin, VA; Marques, RA; Phillips, TL; Sadee, W; VanRaalte, G; Wasserman, TH | 1 |
Anderson, P; Dische, S; Flockhart, IR; Lee, ME; Saunders, MI | 1 |
Kogelnik, HD; Mamoli, B; Müller, M; Rathkolb, O; Wessely, P | 1 |
Buswell, L; Coleman, CN; Noll, L; Riese, N; Rose, MA | 1 |
Coleman, CN; Halsey, J; Hancock, S; Noll, L; Phillips, TL; Urtasun, RC; Wasserman, TH | 1 |
Bleehen, NM; Maughan, TS; Newman, HF; Workman, P | 1 |
Boegman, RJ; Dragovic, L; Robertson, DM; Scarth, B | 1 |
Coleman, CN; Halsey, J; Hancock, S; Hirst, VK; Phillips, TL; Urtasun, RC; Wasserman, TH | 1 |
Blaschke, T; Coleman, CN; Cox, RS; Halsey, J; Hancock, S; Hirst, VK; Howes, AE; Pajak, T; Urtasun, RC; Wasserman, TH | 1 |
12 trial(s) available for azomycin and Peripheral Nervous System Diseases
Article | Year |
---|---|
Misonidazole neuropathy.
Topics: Aged; Female; Humans; Laryngeal Neoplasms; Lung Neoplasms; Male; Middle Aged; Misonidazole; Nitroimidazoles; Peripheral Nerves; Peripheral Nervous System Diseases; Pharyngeal Neoplasms | 1984 |
Experience in the radical radiotherapy of cancer in the bilharzial bladder: the use of misonidazole.
Topics: Aged; Female; Follow-Up Studies; Humans; Kidney; Male; Middle Aged; Misonidazole; Nitroimidazoles; Peripheral Nervous System Diseases; Radiotherapy; Schistosomiasis; Urinary Bladder Diseases; Urinary Bladder Neoplasms | 1984 |
Clinical experience with misonidazole: high dose fractions versus daily low doses.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Eruptions; Epilepsy; Female; Hearing Loss; Humans; Male; Middle Aged; Misonidazole; Neurocognitive Disorders; Nitroimidazoles; Peripheral Nervous System Diseases | 1980 |
A phase I study of misonidazole and pelvic irradiation in patients with carcinoma of cervix.
Topics: Double-Blind Method; Drug Evaluation; Female; Hearing Loss; Humans; Kinetics; Misonidazole; Nitroimidazoles; Peripheral Nervous System Diseases; Random Allocation; Thrombocytopenia; Uterine Cervical Neoplasms | 1982 |
Dose-response curves for predicting misonidazole-induced peripheral neuropathy.
Topics: Clinical Trials as Topic; Dose-Response Relationship, Drug; Esophageal Neoplasms; Half-Life; Humans; Injections, Intravenous; Kinetics; Metabolic Clearance Rate; Misonidazole; Nitroimidazoles; Osteosarcoma; Peripheral Nervous System Diseases; Probability | 1982 |
Misonidazole combined with radiotherapy in the treatment of inoperable squamous cell carcinoma of the lung. A double-blind randomized trial.
Topics: Aged; Carcinoma, Squamous Cell; Double-Blind Method; Esophagitis; Humans; Lung Neoplasms; Misonidazole; Nitroimidazoles; Peripheral Nervous System Diseases; Placebos; Pneumonia; Radiation Injuries; Radiotherapy Dosage; Random Allocation; Vomiting | 1983 |
A study of the effect of misonidazole in conjunction with radiotherapy for the treatment of head and neck cancer. MRC working party on misonidazole in head and neck cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Clinical Trials as Topic; Combined Modality Therapy; Double-Blind Method; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Misonidazole; Nitroimidazoles; Peripheral Nervous System Diseases; Radiotherapy; Radiotherapy Dosage; Random Allocation | 1984 |
Initial United States clinical and pharmacologic evaluation of misonidazole (Ro-07-0582), an hypoxic cell radiosensitizer.
Topics: Administration, Oral; Drug Administration Schedule; Drug Evaluation; Humans; Misonidazole; Nausea; Neoplasms; Nitroimidazoles; Peripheral Nervous System Diseases; Sensation; Vomiting | 1979 |
Misonidazole-a drug for trial in radiotherapy and oncology.
Topics: Anorexia; Clinical Trials as Topic; Drug Eruptions; Female; Humans; Male; Misonidazole; Nausea; Neoplasms; Nitroimidazoles; Peripheral Nervous System Diseases; Seizures | 1979 |
The efficacy of pharmacokinetic monitoring and dose modification of etanidazole on the incidence of neurotoxicity: results from a phase II trial of etanidazole and radiation therapy in locally advanced prostate cancer.
Topics: Adenocarcinoma; Combined Modality Therapy; Drug Evaluation; Etanidazole; Humans; Male; Nitroimidazoles; Peripheral Nervous System Diseases; Prostatic Neoplasms; Radiation-Sensitizing Agents | 1992 |
Final report of the phase I trial of the hypoxic cell radiosensitizer SR 2508 (etanidazole) Radiation Therapy Oncology Group 83-03.
Topics: Adult; Canada; Combined Modality Therapy; Drug Evaluation; Etanidazole; Humans; Infusions, Intravenous; Multicenter Studies as Topic; Neoplasms; Nitroimidazoles; Peripheral Nervous System Diseases; Radiation-Sensitizing Agents; United States | 1990 |
A multiple dose study of the combined radiosensitizers Ro 03-8799 (pimonidazole) and SR 2508 (etanidazole).
Topics: Drug Combinations; Etanidazole; Humans; Neoplasms; Nitroimidazoles; Peripheral Nervous System Diseases; Radiation-Sensitizing Agents | 1989 |
19 other study(ies) available for azomycin and Peripheral Nervous System Diseases
Article | Year |
---|---|
Tolerance of benznidazole in a United States Chagas Disease clinic.
Topics: Adolescent; Adult; Aged; Angioedema; Chagas Disease; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Nitroimidazoles; Peripheral Nervous System Diseases; Retrospective Studies; Trypanocidal Agents; United States; Young Adult | 2015 |
[Peripheral neuropathy during treatment with ornidazole].
Topics: Adolescent; Critical Care; Follow-Up Studies; Humans; Male; Metronidazole; Nitroimidazoles; Ornidazole; Peripheral Nervous System Diseases | 1984 |
The current status of drug development of hypoxic cell radiosensitizers and their potential role in gynecologic oncology.
Topics: Adult; Aged; Drug Evaluation; Female; Genital Neoplasms, Female; Humans; Middle Aged; Misonidazole; Neoplasm Recurrence, Local; Nitroimidazoles; Oxygen; Palliative Care; Peripheral Nervous System Diseases; Radiation-Sensitizing Agents | 1984 |
The neurotoxicity of misonidazole: potential modifying role of phenytoin sodium and dexamethasone.
Topics: Central Nervous System Diseases; Dexamethasone; Drug Interactions; Half-Life; Humans; Misonidazole; Nitroimidazoles; Peripheral Nervous System Diseases; Phenytoin | 1980 |
Misonidazole peripheral neuropathy: its relationship to plasma concentration and other drugs.
Topics: Adrenal Cortex Hormones; Barbiturates; Brain Neoplasms; Drug Interactions; Female; Glioma; Half-Life; Humans; Male; Middle Aged; Misonidazole; Nitroimidazoles; Peripheral Nervous System Diseases; Phenytoin | 1980 |
Neurotoxicity with desmethylmisonidazole.
Topics: Female; Humans; Misonidazole; Nitroimidazoles; Peripheral Nervous System Diseases | 1981 |
Final report on the United States Phase I Clinical Trial of the hypoxic cell radiosensitizer, misonidazole (Ro-07-0582; NSC #261037).
Topics: Adolescent; Adult; Aged; Central Nervous System Diseases; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Female; Hearing Loss; Humans; Male; Middle Aged; Misonidazole; Nausea; Nitroimidazoles; Peripheral Nervous System Diseases; Vomiting | 1981 |
A biochemical assessment of the neurotoxicity of the radiosensitizing drug misonidazole in the rat.
Topics: Animals; beta-Galactosidase; Body Weight; Cerebellum; Culture Techniques; Female; Glucuronidase; Male; Misonidazole; Nitroimidazoles; Peripheral Nervous System Diseases; Rats; Rats, Inbred Strains; Trigeminal Nerve | 1981 |
Plasma concentration of misonidazole and peripheral neuropathy.
Topics: Half-Life; Humans; Liver; Misonidazole; Nitroimidazoles; Peripheral Nervous System Diseases | 1982 |
The use of misonidazole in association with a three-fractions per day regimen in advanced head and neck epidermoid cancer. A pilot study.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Erythema; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Misonidazole; Nitroimidazoles; Peripheral Nervous System Diseases; Pilot Projects; Radiotherapy Dosage | 1983 |
The neurotoxicity of misonidazole and its relationship to dose, half-life and concentration in the serum.
Topics: Drug Administration Schedule; Half-Life; Humans; Neoplasms; Nitroimidazoles; Peripheral Nervous System Diseases; Radiation-Sensitizing Agents | 1978 |
Peripheral neuropathy related to misonidazole: incidence and pathology.
Topics: Drug Administration Schedule; Female; Humans; Middle Aged; Neoplasms; Neural Conduction; Nitroimidazoles; Peripheral Nervous System Diseases; Radiation-Sensitizing Agents; Sural Nerve | 1978 |
Further clinical experiences of a phase I study with the hypoxic cell radiosensitizer misonidazole.
Topics: Adolescent; Adult; Drug Administration Schedule; Drug Evaluation; Female; Humans; Male; Middle Aged; Neurocognitive Disorders; Nitroimidazoles; Peripheral Nervous System Diseases; Radiation-Sensitizing Agents | 1978 |
The optimum regime for the administration of misonidazole and the establishment of multi-centre clinical trials.
Topics: Drug Administration Schedule; Humans; Neoplasms; Nitroimidazoles; Peripheral Nervous System Diseases; Radiation-Sensitizing Agents; Research Design | 1978 |
The neurotoxicity of misonidazole: pooling of data from five centres.
Topics: Dose-Response Relationship, Drug; Humans; Misonidazole; Nitroimidazoles; Peripheral Nervous System Diseases | 1978 |
Electroneurographic investigations of misonidazole polyneuropathy.
Topics: Action Potentials; Adult; Aged; Female; Humans; Male; Middle Aged; Misonidazole; Motor Neurons; Neoplasms; Nerve Fibers; Neural Conduction; Nitroimidazoles; Peripheral Nerves; Peripheral Nervous System Diseases; Peroneal Nerve; Sural Nerve; Time Factors | 1979 |
Neurotoxicity of Adriamycin and misonidazole in the mouse.
Topics: Animals; Doxorubicin; Lysosomes; Male; Misonidazole; Muridae; Nitroimidazoles; Peripheral Nervous System Diseases; Sciatic Nerve | 1985 |
Phase I trial of the hypoxic cell radiosensitizer SR-2508: the results of the five to six week drug schedule.
Topics: Drug Administration Schedule; Drug Evaluation; Etanidazole; Humans; Nitroimidazoles; Peripheral Nervous System Diseases; Radiation-Sensitizing Agents | 1986 |
Relationship between the neurotoxicity of the hypoxic cell radiosensitizer SR 2508 and the pharmacokinetic profile.
Topics: Dose-Response Relationship, Drug; Drug Administration Schedule; Etanidazole; Humans; Kinetics; Misonidazole; Nitroimidazoles; Peripheral Nervous System Diseases; Radiation-Sensitizing Agents | 1987 |